Thermo Fisher Scientific TMO Instruments — Consolidated revenues

Other product segments

Similar metrics at other companies

DFHFinancial Services — Consolidated revenues

$51.18M+159%

TEC

TECHInstruments — Revenue

$27.66M+5.9%

ALM

ALMRInstruments — Revenue

$7.38M+78.0%

TXGInstruments — Revenue

$11.26M-24.0%

RDNTOther revenue — Total consolidated revenues

$24.8M+97.8%

QTRXInstruments — Total revenues

$4.1M+56.2%

FAQ

What is Thermo Fisher Scientific's instruments — consolidated revenues?

Thermo Fisher Scientific (TMO) reported instruments — consolidated revenues of $1.56B in Q1 2026.

How has Thermo Fisher Scientific's instruments — consolidated revenues changed year-over-year?

Thermo Fisher Scientific's instruments — consolidated revenues decreased by 4.4% year-over-year, from $1.63B to $1.56B.

What is the long-term trend for Thermo Fisher Scientific's instruments — consolidated revenues?

Over 4 years (2021 to 2025), Thermo Fisher Scientific's instruments — consolidated revenues has grown at a -1.5% compound annual growth rate (CAGR), from $7.75B to $7.3B.

What does instruments — consolidated revenues mean?

This metric represents the total net sales generated by the business unit focused on scientific instruments and analytical hardware. It captures the revenue stream derived from the sale of long-lived capital equipment used in laboratory, research, and diagnostic settings. This segment serves as a primary indicator of the company's ability to capture market share in high-value hardware deployments.